Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands
Schnog John-John, Medical Doctor at Curacao Medical Center, shared a post on X:
“Cancer patient advocacy organizations (cPAOs) are instrumental for providing support, information and lobbying for high quality cancer care. We have studied whether Pharma funding of cPAOs occurs in the Netherlands. Funding by Pharma is common.”
Ash Paul, Public Health Doctor in United Kingdom, shared a post on X:
“Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands via Schnog John-John et al”
Timothée Olivier shared the post by Ash Paul on X, adding:
“Congratulations to Schnog John-John and his team for this outstanding paper!!
Financial $$$ conflicts of interest in patient advocacy organizations are almost a “taboo” subject…yet key to be aware of !”
Further Reading.
Source: Timothée Olivier/X , Ash Paul/X and Schnog John-John/X
Timothée Olivier is a medical oncologist at the Oncology Division of Geneva University Hospital in Switzerland. He also serves as a visiting researcher at the University of California, San Francisco. His research focuses on meta-research, evidence-based medicine, health policy, drug regulation, quality of life, medical education, and screening.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023